Marijuana is used both recreationally for its mood-altering effects and medically for a growing list of conditions, most commonly chronic pain, chemotherapy-induced nausea, epilepsy, and muscle spasticity from multiple sclerosis. The plant contains over a hundred active compounds called cannabinoids, with THC producing the well-known “high” and CBD offering therapeutic effects without intoxication. But marijuana’s story is not neatly split into “helpful” and “harmful.” The same substance that eases nerve pain in one person can trigger psychosis in another, and the evidence behind many of its uses is thinner than the enthusiasm around them.
Pain Management
Chronic pain is the single most common reason people seek medical marijuana. The evidence here is real but modest. A large systematic review and meta-analysis of randomized trials found that non-inhaled cannabis probably produces a small but meaningful improvement in pain compared with placebo, with roughly 10% more patients reaching a clinically noticeable level of relief.1BMJ. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials That is a genuine effect, but it is not dramatic. Across the broader literature, cannabinoids show moderate benefit for neuropathic pain, fibromyalgia, cancer-related pain, and spasticity-linked pain, though much of the evidence comes from small studies with methodological issues.2PubMed Central. Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks
An earlier meta-analysis found a moderate effect size favoring cannabis over placebo for chronic pain generally, but the same review warned that the benefits could be partially or completely offset by harms.3Pain Medicine. Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain That tension runs through everything we know about marijuana as medicine: there are real effects, but the therapeutic window is narrow and the side-effect profile is not trivial.
Many patients report viewing cannabis as a safer alternative to opioids, and some research supports a potential opioid-sparing effect, meaning people who use cannabis for pain sometimes reduce their opioid intake. That perception drives a lot of medical marijuana use, even though the quality of evidence behind it remains limited.
Nausea and Cancer Supportive Care
One of the earliest and best-supported medical uses of cannabis is controlling nausea and vomiting caused by chemotherapy. A systematic review of 30 studies found that cannabinoid-based drugs outperformed both placebo and older anti-nausea medications, and when patients were asked which treatment they preferred, the vast majority chose the cannabinoid.4PubMed. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis Two pharmaceutical cannabinoids, dronabinol and nabilone, have been available by prescription for this purpose for decades.
Beyond nausea, clinical evidence in cancer patients is beginning to support cannabis use for loss of appetite, pain, and nerve damage from chemotherapy. Data from other populations suggest it could also help with gut distress, anxiety, and sleep problems in people undergoing treatment.5PubMed Central. Opportunities for cannabis in supportive care in cancer Cannabis does not treat cancer itself, but for people enduring harsh treatment regimens, the supportive care benefits can make a real difference in quality of life.
Epilepsy
This is arguably where the science is strongest. CBD, the non-intoxicating cannabinoid, received FDA approval in 2018 as Epidiolex for treating severe, treatment-resistant forms of epilepsy in children. A meta-analysis of randomized trials found that CBD treatment more than doubled the odds of achieving at least a 50% reduction in seizures across Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.6PubMed. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis Separate research confirmed that CBD can reduce seizure frequency whether or not patients are also taking clobazam, a standard epilepsy drug.7PubMed. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam
The epilepsy evidence is worth highlighting because it represents the clearest case of a cannabinoid going through rigorous clinical testing and proving its value. Most other medical uses of marijuana rely on observational data, patient surveys, or small trials. Epidiolex went through the standard pharmaceutical approval process, which is why it can be prescribed in all fifty U.S. states regardless of marijuana legality.
Multiple Sclerosis and Spasticity
Muscle spasticity, the stiffness and involuntary spasms common in multiple sclerosis, is another area with reasonable evidence. Nabiximols, an oromucosal spray containing both THC and CBD, has been approved in several countries for MS-related spasticity. Clinical reviews have found that both the spray and oral cannabinoids improve spasticity, pain, and quality of life in MS patients, with tolerable side effects.8PubMed Central. The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
A randomized controlled trial found that a cannabis-based medicine was significantly better than placebo for spasticity, with 40% of patients achieving more than 30% improvement.9European Journal of Neurology. Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis Another crossover trial in patients whose spasticity had not responded to other drugs found that a cannabis extract reduced spasm frequency and improved mobility.10Multiple Sclerosis Journal. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis For people with MS who have tried other treatments without relief, cannabis-based options represent a genuine additional tool.
PTSD and Sleep
Many people with post-traumatic stress disorder turn to marijuana, particularly for nightmares and insomnia. A pilot study found that PTSD symptom severity dropped significantly within 30 days of starting medical marijuana, with patients sleeping roughly an hour and a half longer per night and reporting meaningfully better sleep quality. Nightmares improved as well, though that took longer to show up.11PubMed Central. Improved Post-Traumatic Stress Disorder Symptoms and Related Sleep Disturbances after Initiation of Medical Marijuana Use
A daily diary study of PTSD patients found that using cannabis closer to bedtime was linked to fewer nightmares, and people who used higher-CBD products reported fewer middle-of-the-night awakenings.12PubMed. Posttraumatic stress disorder, sleep and medical cannabis treatment: A daily diary study The evidence here is still early stage, with small samples and no blinding, so the results need to be taken with some caution. But PTSD is hard to treat, and the subjective improvements patients report are consistent enough that researchers are taking the signals seriously.
Psychosis Risk and High-Potency Cannabis
If the medical-use section makes marijuana sound mostly helpful, this is where the picture gets complicated. The link between cannabis and psychosis is one of the most robust findings in the field. A study of first-episode psychosis patients found that 78% had used high-potency cannabis, compared with 37% of healthy controls, translating to roughly a sevenfold increase in odds.13PubMed Central. High-potency cannabis and the risk of psychosis The key variable is THC concentration. Today’s cannabis products are far stronger than what was available a few decades ago, and the evidence consistently points to daily use of high-potency products as the highest-risk pattern.14Psychological Medicine. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients
This is not the same as saying marijuana causes schizophrenia in everyone who uses it. Most users never develop psychosis. But in people who are genetically vulnerable, heavy use of strong THC products appears to act as a trigger. The risk rises with potency, frequency, and earlier age of first use. If you have a family history of psychotic illness, this is information worth taking seriously.
Effects on the Brain
Marijuana’s acute effects on the brain are familiar to anyone who has used it: altered time perception, impaired short-term memory, changes in mood and coordination. Those effects clear as the drug wears off. The more important question is what happens with long-term use.
A recent neuroimaging study found that heavy lifetime cannabis use was associated with lower brain activation during working memory tasks, with affected regions including areas involved in attention, decision-making, and executive function.15JAMA Network Open. Brain Function Outcomes of Recent and Lifetime Cannabis Use Recent use also correlated with poorer performance on working memory and motor tasks, though those associations were weaker after statistical correction.
For adolescents, the concerns are sharper. Research has found attention and memory disadvantages that persist even after people stop using, along with possible structural changes in brain tissue and alterations in white matter integrity. Earlier initiation and more frequent use are tied to worse outcomes.16PubMed Central. Effects of Cannabis on the Adolescent Brain A review of the evidence found functional brain alterations in cannabis-using adolescents but raised a genuinely important wrinkle: some differences in brain structure appear to predate cannabis use, making it unclear how much is caused by marijuana and how much reflects pre-existing vulnerabilities.17PubMed. Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence A twin study reached a similar conclusion, finding that the association between adolescent marijuana use and IQ decline could be explained by shared family and genetic factors rather than the drug itself.18Proceedings of the National Academy of Sciences. Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
None of this means teenage marijuana use is harmless. The developing brain is more vulnerable to disruption than the adult brain, and the balance of evidence still supports caution. But the headline claim that marijuana straightforwardly lowers your IQ is probably too simple.
Addiction and Withdrawal
The old claim that marijuana is not addictive has not held up. Cannabis use disorder is a recognized diagnosis, and about half of regular users experience withdrawal symptoms after stopping abruptly. Those symptoms typically start within a day or two and peak around days two through six, though some can linger for three weeks or more in heavy users.19Addiction. Clinical management of cannabis withdrawal
Common withdrawal symptoms include anxiety, irritability, anger, disrupted sleep with vivid dreams, low mood, and loss of appetite. Less frequently, people experience chills, headaches, sweating, and stomach pain. The severity is nowhere near alcohol or opioid withdrawal, and cannabis withdrawal is not life-threatening, but it is real enough to keep many people using when they would rather not.
Cardiovascular and Respiratory Concerns
Marijuana’s effects on the heart and blood vessels are underappreciated. Acute use raises blood pressure and heart rate. Cannabis consumption has been linked to arrhythmias, heart attacks, and ischemic stroke, particularly in younger, otherwise healthy users. These risks appear to be worse when combined with cigarette smoking and during physical exertion in the hours after use.20PubMed Central. Role of cannabis in cardiovascular disorders The American Heart Association has flagged cardiovascular disease as a concerning health implication of cannabis, noting that the method of delivery may play a role in the degree of risk.21Circulation. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
On the respiratory side, even vaping cannabis is not benign. A study of young adults found that vaping cannabis was associated with bronchitis-like symptoms and wheezing at every level of use, even after accounting for tobacco and other smoking habits. People who vaped cannabis three or more days per month had more than double the odds of wheezing compared with non-users.22PubMed Central. Assessment of Nicotine and Cannabis Vaping and Respiratory Symptoms in Young Adults The assumption that vaping sidesteps the lung problems of smoking may be premature.
Cannabinoid Hyperemesis Syndrome
One of the stranger complications of long-term marijuana use is cannabinoid hyperemesis syndrome, or CHS. It causes repeated episodes of severe nausea, vomiting, and abdominal pain, and it almost exclusively affects people who have been using cannabis regularly for months or years.23PubMed Central. Cannabinoid hyperemesis relieved by compulsive bathing The condition is paradoxical: marijuana is supposed to reduce nausea, but in CHS it does the opposite. Standard anti-nausea drugs often fail to help.24PubMed. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment
A hallmark of CHS is that hot showers or baths provide dramatic but temporary relief. A systematic review found that compulsive hot bathing with symptom relief occurred in over 90% of cases, and nearly all patients used cannabis at least weekly. The condition resolves after stopping cannabis, and it comes back if use resumes.25PubMed Central. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review CHS was once considered rare, but emergency departments are seeing it more frequently as cannabis potency and use have increased. If you are a daily user experiencing cyclical vomiting that doctors cannot explain, this diagnosis is worth raising.
How THC and CBD Work Differently
The two most discussed cannabinoids act through very different pathways, which explains why their effects diverge so sharply. THC binds directly to cannabinoid receptors in the brain, particularly CB1 receptors concentrated in areas governing mood, memory, coordination, and pain perception. That binding is responsible for both the high and many of the therapeutic effects, as well as the risks.26PubMed Central. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
CBD does not produce intoxication. It interacts with a wider set of receptors and has shown anti-inflammatory, anti-seizure, anti-anxiety, and pain-relieving properties in research settings.27Basic & Clinical Pharmacology & Toxicology. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD) This is why CBD-only products have become popular among people who want potential health benefits without feeling stoned. The trade-off is that CBD on its own does not help with every condition cannabis has been used for, and many of the bolder claims made about CBD products outrun the evidence.
Cannabis also contains terpenes, the aromatic compounds responsible for the plant’s smell. There is a popular idea called the “entourage effect,” which holds that terpenes and cannabinoids work together more effectively than isolated compounds.28PubMed Central. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders Exploratory research does suggest individual terpenes may have their own biological effects, such as relaxation or pain relief, but a comprehensive review found that the synergistic enhancement of cannabinoid action by terpenes remains unproven.29PubMed Central. The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review The entourage effect is a plausible hypothesis, not a settled fact.
Drug Interactions
An underappreciated concern for medical users is how cannabis interacts with other medications. Both THC and CBD are processed by the same liver enzymes that metabolize a long list of common drugs, including blood thinners, certain antidepressants, anti-seizure medications, and immunosuppressants. This means cannabis can change how quickly your body clears those drugs, potentially making them either less effective or more toxic.30PubMed Central. Evaluation of potential drug-drug interactions with medical cannabis If you take prescription medications and are considering cannabis, that conversation with your doctor is not optional.
Pregnancy and Young Children
Cannabis use during pregnancy is rising, often driven by the belief that it is natural and therefore safe. The evidence says otherwise. THC crosses the placenta freely and appears in breast milk. Reviews have linked prenatal exposure to restricted fetal growth, and an emerging body of evidence points to neurodevelopmental effects in children, including hyperactivity, poorer cognitive function, and changes in brain chemistry that can persist into young adulthood.31PubMed. Marijuana use in pregnancy and lactation: a review of the evidence32PubMed Central. Marijuana Use in Pregnancy: A Review There is no established safe level of use during pregnancy or while breastfeeding.33PubMed Central. Cannabis use during pregnancy and postpartum
Separately, accidental cannabis ingestion by young children has become a growing emergency-room problem as edible products have proliferated. Common symptoms in children include drowsiness and vomiting, but severe cases can involve respiratory depression and seizures.34PubMed Central. Accidental cannabis ingestion in young children Edibles that look like candy or gummy bears are a particular hazard. If you have cannabis products at home and children in your life, childproof storage is essential.